-
EP0337628
European procedure
Extract from the Register of European Patents
EP About this file: EP0337628
| EP0337628 - 3-Substituted-2-oxindole-1-carboxamides for suppressing T-cell function [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 31.03.1994 Database last updated on 15.06.2024 | Most recent event Tooltip | 31.03.1994 | No opposition filed within time limit | published on 25.05.1994 [1994/21] | Applicant(s) | For all designated states Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US | [N/P] |
| Former [1989/42] | For all designated states PFIZER INC. 235 East 42nd Street New York, N.Y. 10017 / US | Inventor(s) | 01 /
Showell, Henry James 24, Pepperidge Trail Old Saybrook State of Connecticut / US | [1989/42] | Representative(s) | Moore, James William Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ / GB | [N/P] |
| Former [1989/42] | Moore, James William, Dr. Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ / GB | Application number, filing date | 89303050.2 | 28.03.1989 | [1989/42] | Priority number, date | US19880181142 | 13.04.1988 Original published format: US 181142 | [1989/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0337628 | Date: | 18.10.1989 | Language: | EN | [1989/42] | Type: | A3 Search report | No.: | EP0337628 | Date: | 02.01.1991 | Language: | EN | [1991/01] | Type: | B1 Patent specification | No.: | EP0337628 | Date: | 26.05.1993 | Language: | EN | [1993/21] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 14.11.1990 | Classification | IPC: | A61K31/40 | [1989/42] | CPC: |
A61K31/40 (EP,KR,US);
A61P37/00 (EP)
| Designated contracting states | AT, BE, CH, DE, FR, GB, IT, LI, LU, NL, SE [1989/42] | Title | German: | 3-Substituierte 2-Oxindol-1-carboxamid-Derivate zur Hemmung der Aktivität der T-Zellen | [1989/42] | English: | 3-Substituted-2-oxindole-1-carboxamides for suppressing T-cell function | [1989/42] | French: | Dérivés du 2-oxindole-1-carboxamide substitués en position 3, utilisés pour supprimer l'activité des cellules T | [1989/42] | Examination procedure | 05.04.1989 | Examination requested [1989/42] | 27.01.1992 | Despatch of a communication from the examining division (Time limit: M06) | 27.07.1992 | Reply to a communication from the examining division | 11.08.1992 | Despatch of a communication from the examining division (Time limit: M02) | 18.09.1992 | Reply to a communication from the examining division | 27.10.1992 | Despatch of communication of intention to grant (Approval: Yes) | 02.12.1992 | Communication of intention to grant the patent | 03.02.1993 | Fee for grant paid | 03.02.1993 | Fee for publishing/printing paid | Opposition(s) | 01.03.1994 | No opposition filed within time limit [1994/21] | Fees paid | Renewal fee | 28.12.1990 | Renewal fee patent year 03 | 07.01.1992 | Renewal fee patent year 04 | 29.12.1992 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | EP0156603 [ ] (PFIZER [US]); | EP0158278 [ ] (HOECHST AG [DE]) | Examination | - The Journal of Immunology, vol. 134, no. 3, March 1985, pages 1914-1919, The American Association of Immunologists; V.E. Kelley et al. | - Int. J. Immunopharmac., vol. 4, no. 3, 1982, pp. 195-204; K.H. Leung et al. | - 37th Annual Meeting of the American Academy of Neurology, Dallas, 28th April - 4th May 1985, Neurology, vol. 35, (4 suppl. 1), 1985, p. 297, abstract no. 6; P. Dore-Duffy et al. |